Sign in

CIK 0001706431 · Large accelerated filer

Vir Biotechnology, Inc.

Sign in to watch
Ticker
VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
812730369
Phone
415-906-4324
Business address
1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
  1. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $34.56 ($172,781)
  2. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $33.75 ($46,406)
  3. 8-K Event Other events
  4. 4 Option exercise Chief Medical Officer acquired 5,000 shares (option exercise)
  5. 4 Option exercise EVP, Research & CSO acquired 8,000 shares (option exercise)
  6. 4 Open-market sale EVP, Research & CSO sold 4,125 shares at $50.00 ($206,250)
  7. 4 Open-market sale Director sold 15,174 shares at an average $52.48 ($796,301)
  8. 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $49.69 ($248,462)
  9. 4 Open-market sale EVP, Research & CSO sold 4,125 shares at an average $49.67 ($204,875)
  10. 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $49.58 ($247,879)
  11. 4 Open-market sale Director sold 1,435 shares at $51.15 ($73,400)
  12. 4 Open-market sale EVP, Research & CSO sold 2,750 shares at $50.00 ($137,500)
  13. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $48.00 ($66,000)
  14. 4 Open-market sale Chief Administrative Officer sold 10,000 shares at $50.00 ($500,000)
  15. 4 Open-market sale EVP, Research & CSO sold 13,750 shares at $50.00 ($687,500)
  16. 4 Open-market sale Director sold 15,174 shares at an average $45.05 ($683,611)
  17. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $42.23 ($211,161)
  18. 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $41.00 ($56,375)
  19. 4 Open-market sale Chief Medical Officer sold 5,000 shares at $34.92 ($174,604)
  20. 10-Q Report Quarterly Report

Page 26 of 41 · 806 filings